
Sign up to save your podcasts
Or
Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.
4.4
322322 ratings
Greg Meyers, chief digital and technology officer at Bristol Myers Squibb, explains how AI is transforming pharmaceutical research from hypothesis-driven hunches to data-driven discoveries. Learn how the company is using computational chemistry to engineer breakthrough therapies like a sickle cell treatment heading to human trials, and why they built internal AI tools for 25,000+ employees. Learn more at ai-podcast.nvidia.com.
161 Listeners
154 Listeners
195 Listeners
296 Listeners
107 Listeners
124 Listeners
150 Listeners
71 Listeners
210 Listeners
90 Listeners
516 Listeners
94 Listeners
44 Listeners
44 Listeners
46 Listeners